Linnea
This article was originally published in The Tan Sheet
Executive Summary
New Melilotus (yellow sweet clover) extract for "venous system" support contains coumarin, "the active ingredient in blood-thinning prescription drugs such as Coumadin," according to Swiss-based extract supplier. Linnea, which is introducing the extract to U.S. supplement market, says it has not spoken with FDA regarding whether agency might consider ingredient a "new drug." Cholestin maker Pharmanex removed red yeast rice from its products following court ruling affirming FDA's determination it contains the same active ingredient as Merck's cholesterol-lowering drug Mevacor (1"The Tan Sheet" April 9, p. 3)...
You may also be interested in...
Cholestin Red Yeast Rice Shipments Halted Pending FDA Talks
Pharmanex suspended U.S. shipments of Cholestin April 2 following a federal court decision affirming FDA's determination that the red yeast rice product is a drug, not a dietary supplement.
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.